point of pH 7.6. It showed a peak of absorption at 280 nm and seemed to have no nonprotein chromophoric component.
It was soluble in water but insoluble in ethanol, butanol and acetone, and was stable at pH 4-9 but unstable at pH 2.
AN-3 had no antibacterial activity against Gram-positive and Gram-negative bacteria so far as tested. But, it showed a strong inhibitory effect on a macromolecule permeable mutant of Escherichia coli. It was not mutagenic. It appeared to inhibit synthesis of DNA and RNA without affecting DNA itself. It also inhibited the in vitro cell growth of L1210 and its ED60 was 5 pg,!ml. AN-3 had antitumor activity against Lewis lung carcinoma in mouse in vivo.
After developing a new assay system employing a macromolecule permeable strain and its DNA repair mutants, we searched for new peptide antibiotics with a DNA-interacting property1).
As a result, we found three different kinds of peptide antibiotics, AN-1, AN-3 and AN-7, i.e. their modes of action were different from each other2). Judging from the response of DNA repair mutants to the drug, AN-1 and AN-7 were antibiotics of the DNA-binding type and DNA-degrading type, respectively. AN-3
did not indicate any direct DNA-interacting property.
As reported previously3), the optimal culture conditions for the production of AN-3 were investigated on a laboratory scale, aiming at its large scale production.
This paper describes bench-plant scale fermentation, the successive purification procedure, and some physicochemical and biological properties of AN-3.
A comparison of AN-3 with already discovered peptide antibiotics is also made.
Materials and Methods

Microorganisms
Streptomyces albulus AAP-23 AJ9422 was employed in this study for the production of AN-3. This strain was newly isolated and identified in our laboratory.
Strain MP2, a macromolecule-permeable mutant of Escherichia coli W3876, and UR3, a uvrA and recA defective derivative of MP2, were used for the assay of antibiotic activity1). L7 was a valinesensitive derivative of MP2 and used for the mutagenicity test1).
Media
The seed medium contained 1 % glucose, 1 % starch, 0.5 % polypepton, 0.5 % meat extract, 0.3 NaCI, 1,ug/ml FeSO4 • 7H2O, lag/ml MnSO4 • 4H2O and 0.1 % KH2PO4. The fermentation medium was composed of 2 % glucose, 0.5 % Polypepton, 0.5 % dried yeast, 0.5 % meat extract, 0.5 % NH4NO3, 0.5 NaCl, 20 µg/ml MnSO4.4H2O and 0.2% CaCl2.2H2O; the pH was adjusted to 7.0 with NaOH.
The compositions of PM and M3 media, which were employed for the antibacterial assay, and M9V medium used for the mutagenicity test were given in our previous papers' .2) Fermentation S. albulus cells were grown in the seed medium at 29°C for 24 hours and then transferred to the fermentation medium at an inoculum size of 10%. The fermentation was carried out in a jar-fermentor with a working volume of 20 liters at 29°C for 2 days. The air flow rate was 1/2 v/v/minute and the agitation speed 350 rpm. The dissolved oxygen level was maintained above 0.01 atm under these oxygen supply conditions. Determination of Antibacterial Activity Antibacterial activity was measured using UR3, according to the disk assay method described previously1,2). One unit of antibacterial activity was defined as the antibiotic concentration giving a 10 mm (diameter) inhibition zone. One mg of purified AN-3 showed activity equivalent to 109 units.
Mutagenicity Test
One ml of a cell suspension (4 x 108 cells/ml) of E. coli L7 was treated with 1 ml of various concentrations of AN-3 at 37°C for 2 hours. After centrifugation, the cells were washed once with M3 medium, and resuspended in the same medium. An aliquot of the cell suspension was spread on an M9V plate and incubated at 37°C for 4 days. The number of valine resistant mutants appearing on the M9V plate was determined. The mutation frequency was estimated as the number of valine resistant colonies among the survivors.
Antitumor Activity against L1210 In Vitro L1210 leukemia cells were cultured in the presence of various concentrations of AN-3 in EAGLE'S minimum essential medium supplemented with 10% calf serum, 5 Mg/ml cefazolin and 100 ,ug/ml streptomycin at an initial cell density of 6 x 102 cells/ml at 37°C in an incubator with 7 % CO2. After 4 day's cultivation, the cell density was determined under a microscope and the ED50 value determined.
Antitumor Activity In Vivo L1210 leukemia cells (1 x 105) were inoculated into BDF1 mice intraperitoneally.
Twenty four hours after the inoculation, 3~50 mg/kg of AN-3 was injected intraperitoneally daily for 5 days. Antitumor activity was indicated by the increase in life span.
Lewis lung carcinoma cells (1 mm3) were transplanted subcutaneously into BDF1 mice. Twenty four hours after the transplantation, 3 -50 mg/kg of AN-3 was injected intraperitoneally daily for 1 10 days. Antitumor activity was shown by the reduction in tumor size.
Effect of AN-3 on Synthesis of DNA, RNA and Protein E. coli MP2 cells cultured in M3 medium were treated with AN-3 at different concentrations for various periods of time at 37°C with shaking. Cells were collected by centrifugation, washed with M3 medium, and then resuspended in the same medium. To 0.5 ml of the cell suspension, 1 uCi of [methyl-3H]thymidine (specific activity , 61.7 Ci/mmol), [5,6-3H] uracil (38.8 Ci/mmol) or [4,5-3H] leucine (65 Ci/ mmol) were added and the suspension was inoculated at 37°C on a shaker. Samples of 0.1 ml were removed from the suspension at different times, transferred to 2 ml of cold 5 % trichloroacetic acid (TCA), and chilled in an ice bath. TCA insoluble materials were collected on a membrane filter and washed four times with 5 % TCA followed by once with 1 % TCA. The filters, after being dried for 30 minutes under a lamp, were soaked in toluene scintillation fluid, and their radioactivities were counted with a liquid scintillation spectrometer. Radioactivities incorporated into each macromolecule were plotted against time and the initial rate of incorporation was calculated.
THE JOURNAL OF ANTIBIOTICS SEPT. 1983 Analysis Cell growth was expressed as packed mycelial volume (PMV) of 2 ml culture. Gel filtration on a column of Bio-Gel P-30 and SDS polyacrylamide gel electrophoresis were employed to determine the molecular weight of AN-3.
The isoelectric point of macromolecular peptide antibiotics was determined with a model SJ-1071 electrofocusing apparatus, Atto Co. Inc., equipped with Servalyt Precortes, pH 3~10.
To determine the amino acid composition, protein samples were hydrolyzed in 6 N HCl at 110°C for 24 hours and then applied to a Hitachi KLA-5 amino acid analyzer.
Chemicals
Neocarzinostatin and bleomycin were obtained from Yamanouchi Pharmaceutical Co., and Nippon Kayaku Company, respectively. Labeled compounds were obtained from New England Nuclear.
Results
Fermentation
The time course of AN-3 production is shown in Fig. 1 . The antibiotic was produced at the late stationary phase of growth, amounting to 90 units/ml. The efficiency of AN-3 production in the jarfermentor was similar to that in a flask scale culture. The purified sample of AN-3 gave a single band on polyacrylamide gel electrophoresis (Fig. 3) . Figs. 4 and 5 show the infrared spectrum and UV absorption spectrum of AN-3, respectively. Both spectra also suggest that AN-3 is a polypeptide. We could not detect any nonprotein chromophoric component in AN-3 by the method employed in detecting one in neocarzinostatin4).
No shoulder or peak in the absorption spectrum other than the peak at 280 nm was found in AN-3 ( Fig. 5) , also suggesting the absence of a chromophore.
Amino acid analysis showed that AN-3 contained various kinds of amino acids, some of which are lacked by other proteinaceous antibiotics (Table 1 ).
AN-3 was stable at pH 4 -9, and very unstable when exposed to pH 2 (Fig. 6 ).
Biological Properties
Antibacterial Activity
The antibacterial activity of AN-3 is summarized in Table 2 . AN-3 showed no antibacterial activity against Gram-positive or Gram-negative bacteria, so far as tested.
The exception was that AN-3
showed a strong inhibitory effect on MP2, a macromolecule permeable mutant of E. coli W3876. AN-3
showed a similar growth inhibitory effect on its uvrA and recA double mutant, UR3. Therefore, as (A) Cells were incubated at the indicated concentrations of AN-3 for 30 minutes.
(B) Cells were incubated for the indicated times with 20 ttg/ml of AN-3. After the incubation and washing of cells, a labeled precursor was added and cultivation was continued.
At intervals aliquots of cultures were withdrawn and subjected to measurement of the incorporation of labeled precursors as described in Materials and Methods. Antitumor Activity of AN-3 AN-3 was examined for its antitumor activity in vitro and in vivo. Neocarzinostatin and bleomycin were also tested as reference antitumor agents. Every peptide antibiotic tested was inhibitory toward the in vitro growth of L1210. When their antitumor activity was examined by using an in vivo assay system with L1210 cells in mouse, only neocarzinostatin was active. AN-3 and bleomycin were found to be effective inhibitors of in vivo development of Lewis lung carcinomas (Table 3) . Discussion AN-3 was isolated and purified from the culture fluid of S. albttlits by using our newly developed procedure. AN-3 appeared to be a novel protein antibiotic for the following reasons. It was different from plurallin5), iyomycin complex6), carzinocidin7), melanomycin8), A-2809), peptimycin10) and lymphomycin11), because purified samples of all these macromolecular antibiotics were reportedly chromogenic as compared to the white powder of AN-3. Neocarzinostatin1 , macromomycin13)and actinoxanthin14) were isolated as antibiotics of an acidic polypeptide nature, but AN-3 is a basic polypeptide.
As for basic peptide antibiotics, AN-3 was different from phenomycin15)and sporamycin16) because AN-3 contained some amino acids which are lacking in other antibiotics.
Phenomycin was deficient in phenylalanine, and sporamycin in histidine, arginine, methionine and proline. AN-3 was completely insoluble in organic solvents and so differed from actinocarcin17) which is soluble in 1-butanol -pyridinewater (1: 1: 2). Two other basic peptide antibiotics, A 2169) and enomycin18) show different pH stabilities from AN-3.
These antibiotics are not very unstable at pH 1 -2, wheras AN-3 is very unstable.
AN-3 has an unique biological property among the macromolecular peptide antibiotics. For the reasons mentioned earlier, AN-3 does not appear to interact directly with DNA to any significant extent.
The non-mutagenic property of AN-3 supports this, since many DNA-interacting chemicals are muta-
genic. Yet, it showed a strong growth inhibitory effect on L1210 cells in vitro and Lewis lung carcinoma tissue in vivo.
Since we could not detect any chromophore in AN-3, the characteristics of AN-3 may in fact reflect the activity of the polypeptide itself.
